Engineering of recombinant soluble CD46: An inhibitor of complement activation

Immunology

Volumn 87, Issue 3, 1996, Pages 348-354

  Christiansen, D ^a   Milland, J ^a   Thorley, B R ^a   Mckenzie, I F C ^a   Mottram, P L ^b   Purcell, L J ^b   Loveland, B E ^a  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT INHIBITOR; MEMBRANE COFACTOR PROTEIN; RECOMBINANT PROTEIN;

AFFINITY CHROMATOGRAPHY; ANIMAL EXPERIMENT; ARTICLE; COMPLEMENT ACTIVATION; GENETIC TRANSFECTION; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT; XENOGRAFT;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD46; BASE SEQUENCE; CHO CELLS; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; CRICETINAE; DNA PRIMERS; FEMALE; GENETIC VECTORS; GRAFT REJECTION; HUMANS; IMMUNOTHERAPY; MALE; MEMBRANE GLYCOPROTEINS; MICE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; POLYMERASE CHAIN REACTION; RATS; RECOMBINANT PROTEINS;

EID: 0029970628     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. REY-CAMPOS J., RUBINSTEIN P. & RODRIGUEZ-DE-CORDOBA S. (1988) A physical map of the human regulator of complement activation gene cluster linking the complement genes CR1, CR2, DAF, and C4BP. J Exp Med 167, 664.
2. DAVIES A. & LACHMANN P.J. (1993) Membrane defence against complement lysis: the structure and biological properties of CD59. Immunol Res 12, 258.
3. COLTEN H.R. & ROSEN F.S. (1992) Complement deficiencies. Annu Rev Immunol 10, 809.
4. NANICHE D., VARIOR-KRISHNAN G., CERVONI F. et al. (1993) Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 67, 6025.
5. DORIG R.E., MARCIL A., CHOPRA A. & RICHARDSON C.D. (1993) The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75, 295.
6. FINGEROTH J.D., WEIS J.J., TEDDER T.F., STROMINGER J.L., BIRO P.A. & FEARON D.T. (1984) Epstein-Barr virus receptor of human B lymphocytes is the C3 d receptor CR2. Proc Natl Acad Sci USA 81, 4510.
7. BOYER V., DELIBRIAS C., NORAZ N., FISCHER E., KAZATCHKINE M.D. & DESGRANGES C. (1992) Complement receptor type 2 mediates infection of the human CD4-negative Raji B-cell line with opsonized HIV. Scand J Immunol 36, 879.
8. DELIBRIAS C.C., KAZATCHKINE M.D. & FISCHER E. (1993) Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV. Scand J Immunol 38, 183.
9. BERGELSON J.M., CHAN M., SOLOMON K.R., ST-JOHN N.F., LIN H. & FINBERG R.W. (1994) Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc Natl Acad Sci USA 91, 6245.
10. OGLESBY T.J., ALLEN C.J., LISZEWSKI M.K., WHITE D.J. & ATKINSON J.P. (1992) Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J Exp Med 175, 1547.
11. ADAMS E.M., BROWN M.C., NUNGE M., KRYCH M. & ATKINSON J.P. (1991) Contribution of the repeating domains of membrane cofactor protein (CD46) of the complement system to ligand binding and cofactor activity. J Immunol 147, 3005.
12. RUSSELL S.M., SPARROW R.L., MCKENZIE I.F. & PURCELL D.F. (1992) Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing. Eur J Immunol 22, 1513.
13. SEYA T., BALLARD L.L., BORA N.S., KUMAR V., CUI W. & ATKINSON J.P. (1988) Distribution of membrane cofactor protein of complement on human peripheral blood cells. An altered form is found on granulocytes. Eur J Immunol 18, 1289.
14. JOHNSTONE R.W., LOVELAND B.E. & MCKENZIE I.F.C. (1993) Identification and quantification of complement regulator CD46 on normal human tissues. Immunology 79, 341.
15. HARA T., KURIYAMA S., KIYOHARA H., NAGASE Y., MATSUMOTO M. & SEYA T. (1992) Soluble forms of membrane cofactor protein (CD46, MCP) are present in plasma, tears, and seminal fluid in normal subjects. Clin Exp Immunol 89, 490.
16. HOURCADE D., HOLERS M.V. & ATKINSON J.P. (1989) The regulators of complement activation (RCA) gene cluster. Adv Immunol 45, 381.
17. WEISMAN H.F., BARTOW T., LEPPO M.K. et al. (1990) Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249, 146.
18. YEH C.G., MARSH H., CARSON G.R. et al. (1991) Recombinant soluble human complement receptor type 1 inhibits inflammation in the reversed passive arthus reaction in rats. J Immunol 146, 250.
19. MORAN P., BEASLEY H., GORRELL A. et al. (1992) Human recombinant soluble decay accelerating factor inhibits complement activation in vitro and in vivo. J Immunol 149, 1736.
20. PRUITT S.K., BALDWIN W.M., MARSH H.C., LIN S.S., YEH C.G. & BOLLINGER R.R. (1991) The effect of soluble complement receptor type 1 on hyperacute xenograft rejection. Transplantation 52, 868.
21. PRUITT S.K., KIRK A.D., BOLLINGER R.R. et al. (1994) The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 57, 363.
22. ZEHR K.J., HERSKOWITZ A., LEE P.C., KUMAR P., GILLINOV A.M. & BAUMGARTNER W.A. (1994) Neutrophil adhesion and complement inhibition prolongs survival of cardiac xenografts in discordant species. Transplantation 57, 900.
23. HORTON R.M., CAI Z., HO S.N. & PEASE L.R. (1990) Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. BioTechniques 8, 528.
24. PURCELL D.F.J., RUSSELL S.M., DEACON N.J., BROWN M.A., HOOKER D.J. & MCKENZIE I.F.C. (1991) Alternatively spliced RNAs encode several isoforms of CD46 (MCP), a regulator of complement activation. Immunogenetics 33, 335.
25. SAMBROOK J., FRITSCH E.F. & MANIATIS T. (1989) Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbour Laboratory, ME.,
26. KALVAKOLANDU D.V.R., BANDYOPADHYAY S.K., TIWARI R.K. & SEN G.C. (1991) Enhancement of expression of exogenous genes by 2-aminopurine. J Biol Chem 266, 873.
27. SEYA T., HARA T., UENAKA A., NAKAYAMA E. & AKEDO H. (1990) Application of protein A-rosette assay for screening of monoclonal antibodies to human complement regulatory proteins. Compl Inflamm 7, 78.
28. SPARROW R.L. & MCKENZIE I.F.C. (1983) HuLy-m5: a unique antigen physically associated with HLA molecules. Hum Immunol 7, 1.
29. HOGARTH P.M., EDWARDS J., MCKENZIE I.F.C., GODING J.W. & LIEW F.Y. (1982) Monoclonal antibodies to the murine Ly-2.1 cell surface antigen. Immunology 46, 135.
30. GILL S.C. & VON HIPPEL P.H. (1989) Calculation of protein extinction coefficients from amino acid sequence data. Anal Biochem 182, 319.
31. LAEMMLI U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature 227, 680.
32. MORRISSEY J.H. (1981) Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem 117, 307.
33. SEYA T., HARA T., MATSUMOTO M., SUGITA Y. & AKEDO H. (1990) Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46). J Exp Med 172, 1673.
34. MOTTRAM P.L., SMITH J.A., MASON A., MIRISKLAVOS A., DUMBLE L.J. & CLUNIE G.J. (1988) Electrocardiographic monitoring of cardiac transplants in mice. Cardiovasc Res 22, 315.
35. LOVELAND B.E., JOHNSTONE R.W., RUSSELL S.M., THORLEY B.R. & MCKENZIE I.F.C. (1993) CD46 (MCP) confers protection from lysis by xenogeneic antibodies. Transplant Proc 25, 396.
36. KOJIMA A., IWATA K., SEYA T. et al. (1993) Membrane cofactor protein (CD46) protects cells predominantly from alternative complement pathway-mediated C3-fragment deposition and cytolysis. J Immunol 151, 1519.
37. CARRINGTON C.A., RICHARDS A.C., COZZI E., LANGFORD G., YANNOUTSOS N. & WHITE D.J.G. (1995) Expression of human DAF and MCP on pig endothelial cells protects from human complement. Transplant Proc 27, 321.
38. SANDRIN M.S. & LOVELAND B.E. (1994) Xenografts: a solution to the shortage of organs for transplantation. Today's Life Sci 6, 22.